- Danish stocks
- Norwegian stocks
- Swedish stocks
- AktieTorget
- A1M Pharma
- Accelerator Nordic
- AlphaHelix
- AroCell
- Biotech-IgG
- Brighter
- Clinical Laserthermia
- Emotra
- Enzymtica
- Eurocine Vaccines
- European Inst. of Science
- IDL Biotech
- Medfield Diagnostics
- MedicPen
- MediRox
- MediRätt
- Micropos Medical
- PharmaLundensis
- Respiratorius
- Rubicon Life Science
- SensoDetect
- WntResearch
- Orasolv
- Senzime
- SPAGO Imaging
- Vivoline Medical
- First North Stockholm
- OMX Stockholm A-F
- OMX Stockholm G-Z
- AktieTorget
- US stocks
- General discussion
- All posts
The BioP US patent family, who’s next…
Bioporto has filed for more US patents, all related to measurement of NGAL. One thing strikes you when you look at the various applications.
Take a look for yourself – if at first you don´t see the common denominator scroll down
Exclusion patent.
The ratio patent:
The CutOff patent:
scroll down
scroll further
almost there:
the applications are all being examined by Christine Foster. read about ALL the patents that Christine Foster has examined – she must be one very bright lady. http://patents.justia.com/examiner/CHRISTINEFOSTER.html
Anyway – Christine has proven to be somewhat sceptical about the patents of BioPorto, so the breakthrough is remarkable. I think it might be a little premature to say she has changed her mind completely about how she sees things regarding the vital cut-off-patent, but the recent decision seems to imply that she has a less stern perception of NGAL.. Lets hope for a summer of approvals 🙂
When comparing the wrappers – there is one possibly interesting small coincidence. Christine Foster worked on the ratio patent and the exclusion patent almost simultanously. The first (ratio) has – as you already know been granted. The second application (exclusion) – well – no entries since may the 8th… (the last entry before issuing the ratio patent was may 7th)
What can we possibly read into this ? It could be nothing, a mere coincidence …BUT -on the other hand – it could indicate that a decision is imminent. As we all know, such a decision can go both ways (at least – there also the option of requesting amendments, reconsideration upon receiving such etc).
If the same modus operandi and the same patterns we have seen with the Ratio-patent is applicable on the Exclusion Patent – then it will be an interesting next couple of weeks.
Lets not get our hopes up too high – a decision can go either way. A rejection of the exclusion patent does NOT mean than the cut-off patent cannot be issued (but of course it makes it less likely)
You can monitor all Utthenthal applications here:
About Stengaard
BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂
Related posts:
- The Important First US NGAL-patent Today BioPorto was granted their first US patent (the ratio...
- EPO, Oral Proceedings / NGAL cutoff-patent (III) The Reasons for the decision by the EPO, regarding the...
- Todays setback.. what does it mean ? Unofficial translation of todays annoncement : BioPortos NGAL cutoff patent...
- EPO, Oral Proceedings / NGAL cutoff-patent (I) As you are all painfully aware of, EPO (European Patent...
- Phadia, this weeks decision on NGAL patent This week will see the verdict on the NGAL patent...
Ongoing debate
- Lesliejek on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Patrickciz on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Jameskipse on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Rickiehiela on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife